Skip to main content

Advertisement

Springer Nature Link
Log in

Use of nasal high flow oxygen during acute respiratory failure

  • Narrative Review
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

Abstract

Nasal high flow (NHF) has gained popularity among intensivists to manage patients with acute respiratory failure. An important literature has accompanied this evolution. In this review, an international panel of experts assessed potential benefits of NHF in different areas of acute respiratory failure management. Analyses of the physiological effects of NHF indicate flow-dependent improvement in various respiratory function parameters. These beneficial effects allow some patients with severe acute hypoxemic respiratory failure to avoid intubation and improve their outcome. They require close monitoring to not delay intubation. Such a delay may worsen outcome. The ROX index may help clinicians decide when to intubate. In immunocompromised patients, NHF reduces the need for intubation but does not impact mortality. Beneficial physiological effects of NHF have also been reported in patients with chronic respiratory failure, suggesting a possible indication in acute hypercapnic respiratory failure. When intubation is required, NHF can be used to pre-oxygenate patients either alone or in combination with non-invasive ventilation (NIV). Similarly, NHF reduces reintubation alone in low-risk patients and in combination with NIV in high-risk patients. NHF may be used in the emergency department in patients who would not be offered intubation and can be better tolerated than NIV.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Delorme M, Bouchard P-A, Simon M et al (2017) Effects of high-flow nasal cannula on the work of breathing in patients recovering from acute respiratory failure. Crit Care Med 45:1981–1988

    CAS  PubMed  Google Scholar 

  2. Mauri T, Alban L, Turrini C et al (2017) Optimum support by high-flow nasal cannula in acute hypoxemic respiratory failure: effects of increasing flow rates. Intensive Care Med 43:1453–1463

    CAS  PubMed  Google Scholar 

  3. Mauri T, Turrini C, Eronia N et al (2017) Physiologic effects of high-flow nasal cannula in acute hypoxemic respiratory failure. Am J Respir Crit Care Med 195:1207–1215

    PubMed  Google Scholar 

  4. Bräunlich J, Köhler M, Wirtz H (2016) Nasal highflow improves ventilation in patients with COPD. Int J Chron Obstruct Pulmon Dis 11:1077–1085

    PubMed  PubMed Central  Google Scholar 

  5. Corley A, Caruana LR, Barnett AG et al (2011) Oxygen delivery through high-flow nasal cannulae increase end-expiratory lung volume and reduce respiratory rate in post-cardiac surgical patients. Br J Anaesth 107:998–1004

    CAS  PubMed  Google Scholar 

  6. Mauri T, Galazzi A, Binda F et al (2018) Impact of flow and temperature on patient comfort during respiratory support by high-flow nasal cannula. Crit Care 22:120

    PubMed  PubMed Central  Google Scholar 

  7. Messika J, Ben Ahmed K, Gaudry S et al (2015) Use of high-flow nasal cannula oxygen therapy in subjects with ARDS: a 1-year observational study. Respir Care 60:162–169

    PubMed  Google Scholar 

  8. Roca O, Pérez-Terán P, Masclans JR et al (2013) Patients with New York Heart Association class III heart failure may benefit with high flow nasal cannula supportive therapy: high flow nasal cannula in heart failure. J Crit Care 28:741–746

    PubMed  Google Scholar 

  9. Roca O, de Acilu MG, Caralt B et al (2015) Humidified high flow nasal cannula supportive therapy improves outcomes in lung transplant recipients readmitted to the intensive care unit because of acute respiratory failure. Transplantation 99:1092–1098

    PubMed  Google Scholar 

  10. Rello J, Pérez M, Roca O et al (2012) High-flow nasal therapy in adults with severe acute respiratory infection: a cohort study in patients with 2009 influenza A/H1N1v. J Crit Care 27:434–439

    PubMed  Google Scholar 

  11. Sztrymf B, Messika J, Bertrand F et al (2011) Beneficial effects of humidified high flow nasal oxygen in critical care patients: a prospective pilot study. Intensive Care Med 37:1780–1786

    CAS  PubMed  Google Scholar 

  12. Frat JP, Thille AW, Mercat A et al (2015) High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med 372(23):2185–2196

    CAS  PubMed  Google Scholar 

  13. Rochwerg B, Granton D, Wang DX et al (2019) High flow nasal cannula compared with conventional oxygen therapy for acute hypoxemic respiratory failure: a systematic review and meta-analysis. Intensive Care Med 45:563–572

    CAS  PubMed  Google Scholar 

  14. Monro-Somerville T, Sim M, Ruddy J et al (2017) The effect of high-flow nasal cannula oxygen therapy on mortality and intubation rate in acute respiratory failure: a systematic review and meta-analysis. Crit Care Med 45:e449–e456

    PubMed  Google Scholar 

  15. Jones PG, Kamona S, Doran O et al (2016) Randomized controlled trial of humidified high-flow nasal oxygen for acute respiratory distress in the emergency department: the HOT-ER study. Respir Care 61:291–299

    PubMed  Google Scholar 

  16. Makdee O, Monsomboon A, Surabenjawong U et al (2017) High-flow nasal cannula versus conventional oxygen therapy in emergency department patients with cardiogenic pulmonary edema: a randomized controlled trial. Ann Emerg Med 70:465–472.e2

    PubMed  Google Scholar 

  17. Bell N, Hutchinson CL, Green TC et al (2015) Randomised control trial of humidified high flow nasal cannulae versus standard oxygen in the emergency department: high flow oxygen randomised control trial. Emerg Med Australas 27:537–541

    PubMed  Google Scholar 

  18. Rittayamai N, Tscheikuna J, Praphruetkit N, Kijpinyochai S (2015) Use of high-flow nasal cannula for acute dyspnea and hypoxemia in the emergency department. Respir Care 60:1377–1382

    PubMed  Google Scholar 

  19. Tinelli V, Cabrini L, Fominskiy E et al (2019) High flow nasal cannula oxygen vs. conventional oxygen therapy and noninvasive ventilation in emergency department patients: a systematic review and meta-analysis. J Emerg Med 57:322–328

    PubMed  Google Scholar 

  20. Doshi P, Whittle JS, Bublewicz M et al (2018) High-velocity nasal insufflation in the treatment of respiratory failure: a randomized clinical trial. Ann Emerg Med 72:73–83.e5

    PubMed  Google Scholar 

  21. García-de-Acilu M, Marin-Corral J, Vázquez A et al (2017) Hypoxemic patients with bilateral infiltrates treated with high-flow nasal cannula present a similar pattern of biomarkers of inflammation and injury to acute respiratory distress syndrome patients. Crit Care Med 45:1845–1853

    PubMed  Google Scholar 

  22. Roca O, Messika J, Caralt B et al (2016) Predicting success of high-flow nasal cannula in pneumonia patients with hypoxemic respiratory failure: the utility of the ROX index. J Crit Care 35:200–205

    PubMed  Google Scholar 

  23. Roca O, Caralt B, Messika J et al (2019) An index combining respiratory rate and oxygenation to predict outcome of nasal high-flow therapy. Am J Respir Crit Care Med 199:1368–1376

    PubMed  Google Scholar 

  24. Bellani G, Laffey JG, Pham T et al (2017) Noninvasive ventilation of patients with acute respiratory distress syndrome. insights from the LUNG SAFE study. Am J Respir Crit Care Med 195:67–77

    PubMed  Google Scholar 

  25. Kang BJ, Koh Y, Lim C-M et al (2015) Failure of high-flow nasal cannula therapy may delay intubation and increase mortality. Intensive Care Med 41:623–632

    PubMed  Google Scholar 

  26. Nedel WL, Deutschendorf C, Moraes Rodrigues Filho E (2017) High-flow nasal cannula in critically ill subjects with or at risk for respiratory failure: a systematic review and meta-analysis. Respir Care 62:123–132

    PubMed  Google Scholar 

  27. Mokart D, Geay C, Chow-Chine L et al (2015) High-flow oxygen therapy in cancer patients with acute respiratory failure. Intensive Care Med 41:2008–2010

    PubMed  Google Scholar 

  28. Coudroy R, Jamet A, Petua P et al (2016) High-flow nasal cannula oxygen therapy versus noninvasive ventilation in immunocompromised patients with acute respiratory failure: an observational cohort study. Ann Intensive Care 6:45

    PubMed  PubMed Central  Google Scholar 

  29. Frat J-P, Ragot S, Girault C et al (2016) Effect of non-invasive oxygenation strategies in immunocompromised patients with severe acute respiratory failure: a post hoc analysis of a randomised trial. Lancet Respir Med 4:646–652

    PubMed  Google Scholar 

  30. Tu G, He H, Yin K et al (2017) High-flow nasal cannula versus noninvasive ventilation for treatment of acute hypoxemic respiratory failure in renal transplant recipients. Transpl Proc 49:1325–1330

    CAS  Google Scholar 

  31. Lemiale V, Resche-Rigon M, Mokart D et al (2017) High-flow nasal cannula oxygenation in immunocompromised patients with acute hypoxemic respiratory failure: a groupe de recherche respiratoire en réanimation onco-hématologique study. Crit Care Med 45:e274–e280

    PubMed  Google Scholar 

  32. Azoulay E, Lemiale V, Mokart D et al (2018) Effect of high-flow nasal oxygen vs standard oxygen on 28-day mortality in immunocompromised patients with acute respiratory failure: the HIGH randomized clinical trial. JAMA 320:2099–2107

    CAS  PubMed  PubMed Central  Google Scholar 

  33. Dumas G, Chevret S, Lemiale V et al (2018) Oxygenation/non-invasive ventilation strategy and risk for intubation in immunocompromised patients with hypoxemic acute respiratory failure. Oncotarget 9:33682–33693

    PubMed  PubMed Central  Google Scholar 

  34. Azoulay E, Pickkers P, Soares M et al (2017) Acute hypoxemic respiratory failure in immunocompromised patients: the Efraim multinational prospective cohort study. Intensive Care Med 43:1808–1819

    PubMed  Google Scholar 

  35. Cortegiani A, Crimi C, Sanfilippo F et al (2019) High flow nasal therapy in immunocompromised patients with acute respiratory failure: a systematic review and meta-analysis. J Crit Care 50:250–256

    PubMed  Google Scholar 

  36. Wang Y, Ni Y, Sun J, Liang Z (2020) Use of high-flow nasal cannula for immunocompromise and acute respiratory failure: a systematic review and meta-analysis. J Emerg Med 58:413–423

    PubMed  Google Scholar 

  37. Pisani L, Vega ML (2017) Use of nasal high flow in stable COPD: rationale and physiology. COPD J Chron Obstruct Pulmon Dis 14:346–350

    Google Scholar 

  38. Ritchie JE, Williams AB, Gerard C, Hockey H (2011) Evaluation of a humidified nasal high-flow oxygen system, using oxygraphy, capnography and measurement of upper airway pressures. Anaesth Intensive Care 39:1103–1110

    CAS  PubMed  Google Scholar 

  39. Bräunlich J, Beyer D, Mai D et al (2013) Effects of nasal high flow on ventilation in volunteers, COPD and idiopathic pulmonary fibrosis patients. Respiration 85:319–325

    PubMed  Google Scholar 

  40. Biselli P, Fricke K, Grote L et al (2018) Reductions in dead space ventilation with nasal high flow depend on physiological dead space volume: metabolic hood measurements during sleep in patients with COPD and controls. Eur Respir J 51:1702251

    PubMed  Google Scholar 

  41. Fraser JF, Spooner AJ, Dunster KR et al (2016) Nasal high flow oxygen therapy in patients with COPD reduces respiratory rate and tissue carbon dioxide while increasing tidal and end-expiratory lung volumes: a randomised crossover trial. Thorax 71:759–761

    PubMed  PubMed Central  Google Scholar 

  42. Pisani L, Fasano L, Corcione N et al (2017) Change in pulmonary mechanics and the effect on breathing pattern of high flow oxygen therapy in stable hypercapnic COPD. Thorax 72:373–375

    PubMed  Google Scholar 

  43. Longhini F, Pisani L, Lungu R et al (2019) High-flow oxygen therapy after noninvasive ventilation interruption in patients recovering from hypercapnic acute respiratory failure: a physiological crossover trial. Crit Care Med 47:e506–e511

    CAS  PubMed  Google Scholar 

  44. Bräunlich J, Mauersberger F, Wirtz H (2018) Effectiveness of nasal highflow in hypercapnic COPD patients is flow and leakage dependent. BMC Pulm Med 18:14

    PubMed  PubMed Central  Google Scholar 

  45. Möller W, Feng S, Domanski U et al (2017) Nasal high flow reduces dead space. J Appl Physiol 122:191–197

    PubMed  Google Scholar 

  46. Bräunlich J, Dellweg D, Bastian A et al (2019) Nasal high-flow versus noninvasive ventilation in patients with chronic hypercapnic COPD. COPD 14:1411–1421

    Google Scholar 

  47. Pisani L, Betti S, Biglia C et al (2020) Effects of high-flow nasal cannula in patients with persistent hypercapnia after an acute COPD exacerbation: a prospective pilot study. BMC Pulm Med 20:12

    CAS  PubMed  PubMed Central  Google Scholar 

  48. Rochwerg B, Brochard L, Elliott MW et al (2017) Official ERS/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure. Eur Respir J 50:1602426

    PubMed  Google Scholar 

  49. Spoletini G, Mega C, Pisani L et al (2018) High-flow nasal therapy vs standard oxygen during breaks off noninvasive ventilation for acute respiratory failure: a pilot randomized controlled trial. J Crit Care 48:418–425

    PubMed  Google Scholar 

  50. Lee MK, Choi J, Park B et al (2018) High flow nasal cannulae oxygen therapy in acute-moderate hypercapnic respiratory failure. Clin Respir J 12:2046–2056

    CAS  PubMed  Google Scholar 

  51. Pilcher J, Eastlake L, Richards M et al (2017) Physiological effects of titrated oxygen via nasal high-flow cannulae in COPD exacerbations: a randomized controlled cross-over trial. Respirology 22:1149–1155

    PubMed  Google Scholar 

  52. Ricard J-D, Dib F, Esposito-Farese M et al (2018) Comparison of high flow nasal cannula oxygen and conventional oxygen therapy on ventilatory support duration during acute-on-chronic respiratory failure: study protocol of a multicentre, randomised, controlled trial. The “HIGH-FLOW ACRF” study. BMJ Open 8:e022983

    PubMed  PubMed Central  Google Scholar 

  53. Cortegiani A, Longhini F, Carlucci A et al (2019) High-flow nasal therapy versus noninvasive ventilation in COPD patients with mild-to-moderate hypercapnic acute respiratory failure: study protocol for a noninferiority randomized clinical trial. Trials 20:450

    PubMed  PubMed Central  Google Scholar 

  54. Ricard JD, Gaborieau B, Bernier J et al (2019) Use of high flow nasal cannula for preoxygenation and apneic oxygenation during intubation. Ann Transl Med 7:S380

    PubMed  PubMed Central  Google Scholar 

  55. Ricard JD (2016) Hazards of intubation in the ICU: role of nasal high flow oxygen therapy for preoxygenation and apneic oxygenation to prevent desaturation. Minerva Anestesiol 82:1098–1106

    PubMed  Google Scholar 

  56. Baillard C, Fosse J-P, Sebbane M et al (2006) Noninvasive ventilation improves preoxygenation before intubation of hypoxic patients. Am J Respir Crit Care Med 174:171–177

    PubMed  Google Scholar 

  57. Baillard C, Prat G, Jung B et al (2018) Effect of preoxygenation using non-invasive ventilation before intubation on subsequent organ failures in hypoxaemic patients: a randomised clinical trial. Br J Anaesth 120:361–367

    CAS  PubMed  Google Scholar 

  58. Papazian L, Corley A, Hess D et al (2016) Use of high-flow nasal cannula oxygenation in ICU adults: a narrative review. Intensive Care Med 42:1336–1349

    CAS  PubMed  Google Scholar 

  59. Miguel-Montanes R, Hajage D, Messika J et al (2015) Use of high-flow nasal cannula oxygen therapy to prevent desaturation during tracheal intubation of intensive care patients with mild-to-moderate hypoxemia. Crit Care Med 43:574–583

    CAS  PubMed  Google Scholar 

  60. Guitton C, Ehrmann S, Volteau C et al (2019) Nasal high-flow preoxygenation for endotracheal intubation in the critically ill patient: a randomized clinical trial. Intensive Care Med 45:447–458

    PubMed  Google Scholar 

  61. Vourc’hVourc’h M, Asfar P, Volteau C et al (2015) High-flow nasal cannula oxygen during endotracheal intubation in hypoxemic patients: a randomized controlled clinical trial. Intensive Care Med 41:1538–1548

    Google Scholar 

  62. Simon M, Wachs C, Braune S et al (2016) High-flow nasal cannula versus bag-valve-mask for preoxygenation before intubation in subjects with hypoxemic respiratory failure. Respir Care 61:1160–1167

    PubMed  Google Scholar 

  63. De Jong A, Jaber S (2016) Apneic oxygenation for intubation in the critically ill. Let’s not give up! Am J Respir Crit Care Med 193:230–232

    PubMed  Google Scholar 

  64. Frat J-P, Ricard J-D, Quenot J-P et al (2019) Non-invasive ventilation versus high-flow nasal cannula oxygen therapy with apnoeic oxygenation for preoxygenation before intubation of patients with acute hypoxaemic respiratory failure: a randomised, multicentre, open-label trial. Lancet Respir Med 7:303–312

    PubMed  Google Scholar 

  65. Jaber S, Monnin M, Girard M et al (2016) Apnoeic oxygenation via high-flow nasal cannula oxygen combined with non-invasive ventilation preoxygenation for intubation in hypoxaemic patients in the intensive care unit: the single-centre, blinded, randomised controlled OPTINIV trial. Intensive Care Med 42:1877–1887

    CAS  PubMed  Google Scholar 

  66. Esteban A, Frutos-Vivar F, Ferguson ND et al (2004) Noninvasive positive-pressure ventilation for respiratory failure after extubation. N Engl J Med 350:2452–2460

    CAS  PubMed  Google Scholar 

  67. Canet J, Gallart L, Gomar C et al (2010) Prediction of postoperative pulmonary complications in a population-based surgical cohort. Anesthesiology 113:1338–1350

    PubMed  Google Scholar 

  68. Stéphan F, Barrucand B, Petit P et al (2015) High-flow nasal oxygen vs noninvasive positive airway pressure in hypoxemic patients after cardiothoracic surgery: a randomized clinical trial. JAMA 313:2331–2339

    PubMed  Google Scholar 

  69. Futier E, Paugam-Burtz C, Godet T et al (2016) Effect of early postextubation high-flow nasal cannula vs conventional oxygen therapy on hypoxaemia in patients after major abdominal surgery: a French multicentre randomised controlled trial (OPERA). Intensive Care Med 42:1888–1898

    CAS  PubMed  Google Scholar 

  70. Thille AW, Boissier F, Ben Ghezala H et al (2015) Risk factors for and prediction by caregivers of extubation failure in ICU patients: a prospective study. Crit Care Med 43:613–620

    PubMed  Google Scholar 

  71. Ferrer M, Valencia M, Nicolas JM et al (2006) Early noninvasive ventilation averts extubation failure in patients at risk: a randomized trial. Am J Respir Crit Care Med 173:164–170

    PubMed  Google Scholar 

  72. Hernández G, Vaquero C, Colinas L et al (2016) Effect of postextubation high-flow nasal cannula vs noninvasive ventilation on reintubation and postextubation respiratory failure in high-risk patients: a randomized clinical trial. JAMA 316:1565–1574

    PubMed  Google Scholar 

  73. Salam A, Tilluckdharry L, Amoateng-Adjepong Y, Manthous CA (2004) Neurologic status, cough, secretions and extubation outcomes. Intensive Care Med 30:1334–1339

    PubMed  Google Scholar 

  74. Hernández G, Vaquero C, González P et al (2016) Effect of postextubation high-flow nasal cannula vs conventional oxygen therapy on reintubation in low-risk patients: a randomized clinical trial. JAMA 315:1354–1361

    PubMed  Google Scholar 

  75. Zhu Y, Yin H, Zhang R et al (2019) High-flow nasal cannula oxygen therapy versus conventional oxygen therapy in patients after planned extubation: a systematic review and meta-analysis. Crit Care 23:180

    PubMed  PubMed Central  Google Scholar 

  76. Thille AW, Muller G, Gacouin A et al (2019) Effect of postextubation high-flow nasal oxygen with noninvasive ventilation vs high-flow nasal oxygen alone on reintubation among patients at high risk of extubation failure: a randomized clinical trial. JAMA 322:1465–1475

    PubMed  PubMed Central  Google Scholar 

  77. Ruangsomboon O, Dorongthom T, Chakorn T et al (2020) High-flow nasal cannula versus conventional oxygen therapy in relieving dyspnea in emergency palliative patients with do-not-intubate status: a randomized crossover study. Ann Emerg Med 75:615–626

    PubMed  Google Scholar 

  78. Epstein AS, Hartridge-Lambert SK, Ramaker JS et al (2011) Humidified high-flow nasal oxygen utilization in patients with cancer at Memorial Sloan-Kettering Cancer Center. J Palliat Med 14:835–839

    PubMed  PubMed Central  Google Scholar 

  79. Peters SG, Holets SR, Gay PC (2013) Nasal high flow oxygen therapy in do-not-intubate patients with hypoxemic respiratory distress. Respir Care 58:597–600

    PubMed  Google Scholar 

  80. Koyauchi T, Hasegawa H, Kanata K et al (2018) Efficacy and tolerability of high-flow nasal cannula oxygen therapy for hypoxemic respiratory failure in patients with interstitial lung disease with do-not-intubate orders: a retrospective single-center study. Respiration 96:323–329

    PubMed  Google Scholar 

  81. Zemach S, Helviz Y, Shitrit M et al (2019) The use of high-flow nasal cannula oxygen outside the ICU. Respir Care 64:1333–1342

    PubMed  Google Scholar 

  82. Hui D, Morgado M, Chisholm G et al (2013) High-flow oxygen and bilevel positive airway pressure for persistent dyspnea in patients with advanced cancer: a phase II randomized trial. J Pain Symptom Manage 46:463–473

    PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

The authors thank Camille Le Breton for her support in drawing Figure n.3.

Author information

Authors and Affiliations

  1. Medico-surgical ICU, Assistance Publique - Hôpitaux de Paris, DMU ESPRIT, Médecine Intensive Réanimation, Hôpital Louis Mourier, 92700, Colombes, France

    Jean-Damien Ricard

  2. Université de Paris, IAME, U1137, Inserm, 75018, Paris, France

    Jean-Damien Ricard

  3. Critical Care Department, Vall d’Hebron University Hospital, Vall d’Hebron Research Institute, Universitat Autònoma de Barcelona, Barcelona, Spain

    Oriol Roca

  4. Ciber Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain

    Oriol Roca

  5. Medical ICU Saint Louis Hospital, APHP, Paris, France

    Virginie Lemiale

  6. Critical Care Research Group, The Prince Charles Hospital, Chermside, Australia

    Amanda Corley

  7. University of Queensland, Brisbane, QLD, Australia

    Amanda Corley

  8. Department of Respiratory Medicine, University of Leipzig, Liebigstraße 20, 04103, Leipzig, Germany

    Jens Braunlich

  9. Klinikum Emden, Bolardusstrasse 20, 26721, Emden, Germany

    Jens Braunlich

  10. School of Medicine, University of Auckland, Auckland, New Zealand

    Peter Jones

  11. Department of Emergency Medicine, Auckland City Hospital, Auckland, New Zealand

    Peter Jones

  12. Department of Internal Medicine, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea

    Byung Ju Kang

  13. Quebec Heart and Lung Institute, Laval University, Québec City, QC, Canada

    François Lellouche

  14. Department of Clinical, Integrated, and Experimental Medicine (DIMES), Respiratory and Critical Care, Sant’Orsola Malpighi Hospital, Bologna, Italy

    Stefano Nava

  15. Division of Respiratory Diseases and Tuberculosis, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand

    Nuttapol Rittayamai

  16. Department of Respiratory Medicine, St James’s University Hospital, Leeds Teaching Hospital NHS Trust, Leeds, UK

    Giulia Spoletini

  17. Leeds Institute for Medical Research, University of Leeds, Leeds, UK

    Giulia Spoletini

  18. Saint Eloi ICU, Montpellier University Hospital and PhyMedExp, INSERM, CNRS, 34000, Montpellier, France

    Samir Jaber

  19. Intensive Care Medicine, University Hospital Virgen de la Salud, Toledo, Spain

    Gonzalo Hernandez

Authors
  1. Jean-Damien Ricard
    View author publications

    You can also search for this author inPubMed Google Scholar

  2. Oriol Roca
    View author publications

    You can also search for this author inPubMed Google Scholar

  3. Virginie Lemiale
    View author publications

    You can also search for this author inPubMed Google Scholar

  4. Amanda Corley
    View author publications

    You can also search for this author inPubMed Google Scholar

  5. Jens Braunlich
    View author publications

    You can also search for this author inPubMed Google Scholar

  6. Peter Jones
    View author publications

    You can also search for this author inPubMed Google Scholar

  7. Byung Ju Kang
    View author publications

    You can also search for this author inPubMed Google Scholar

  8. François Lellouche
    View author publications

    You can also search for this author inPubMed Google Scholar

  9. Stefano Nava
    View author publications

    You can also search for this author inPubMed Google Scholar

  10. Nuttapol Rittayamai
    View author publications

    You can also search for this author inPubMed Google Scholar

  11. Giulia Spoletini
    View author publications

    You can also search for this author inPubMed Google Scholar

  12. Samir Jaber
    View author publications

    You can also search for this author inPubMed Google Scholar

  13. Gonzalo Hernandez
    View author publications

    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence to Jean-Damien Ricard.

Ethics declarations

Conflicts of interest

JDR received travel expenses and accommodation coverage from Fisher&Paykel Healthcare to attend scientific meetings. Fisher&Paykel Healthcare provided support for the ongoing High Flow ACRF trial (NCT03406572) but took no part in design or conduct of the study. OR received speaker fees from Air Liquide. His institution received consultancy fees from Hamilton Medical. VL has no conflict of interest to declare concerning this topic. JB received travel expenses, lecture fees and accommodation coverage from TNI medical AG and Fisher & Paykel Healthcare. TNI medical AG provided support for several NHF trials. AC’s employer, on her behalf, has received travel expenses, lecture fees and accommodation from Fisher & Paykel Healthcare to attend scientific meetings. Fisher & Paykel Healthcare has also provided an unrestricted grant to support investigator driven research, but has had no part in study design, conduct, analysis or reporting of the studies. PJ received competitive grant funding from the A + Trust (4926) and Greenlane Research and Education Fund (12/15/4086) for the HOTER RCT (ACTRN12610000960411) on HFNO in the ED. F&P Healthcare provided equipment for the HOTER RCT for which PJ was the principal investigator, but took no part in design, conduct, analysis or reporting of the study. PJ has no other personal financial or professional to declare. BJK: has no conflict of interest to declare. FL: Fisher&Paykel Healthcare provided support for the development of an application VentilO on optimization of protective mechanical ventilation. SN: Fisher&Paykel Healthcare provided support for the study # NCT03759457. NR received travel expenses and lecture fees from Fisher&Paykel Healthcare. GS: Fisher&Paykel Healthcare provided support for the study # NCT03965832 for which GS is the principal investigator. SJ received personal fees as consultant from Fisher-Paykel. GH received travel expenses coverage and lecture fees from Fisher&Paykel.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 274 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ricard, JD., Roca, O., Lemiale, V. et al. Use of nasal high flow oxygen during acute respiratory failure. Intensive Care Med 46, 2238–2247 (2020). https://doi.org/10.1007/s00134-020-06228-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00134-020-06228-7

Keywords